Cerner Stock Price, News & Analysis (NASDAQ:CERN)

$68.44
+0.76 (+1.12 %)
(As of 09/22/2019 06:28 AM ET)
Today's Range
$67.41
Now: $68.44
$68.63
50-Day Range
$66.50
MA: $69.28
$72.20
52-Week Range
$48.78
Now: $68.44
$76.47
Volume1.72 million shs
Average Volume1.66 million shs
Market Capitalization$21.79 billion
P/E Ratio30.97
Dividend Yield1.06%
Beta0.92
Cerner Corporation provides health care information technology solutions and tech-enabled services in the United States and internationally. The company offers Cerner Millennium architecture, a person-centric computing framework, which includes clinical, financial, and management information systems that allow providers to access an individual's electronic health record (EHR) at the point of care, and organizes and delivers information for physicians, nurses, laboratory technicians, pharmacists, front- and back-office professionals, and consumers. Read More…

Industry, Sector and Symbol

Industry Computer integrated systems design
Sub-IndustryHealth Care Technology
SectorMedical
Current SymbolNASDAQ:CERN
CUSIP15678210
Phone816-221-1024

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$5.37 billion
Cash Flow$4.3044 per share
Book Value$15.19 per share

Profitability

Net Income$630.05 million

Miscellaneous

Employees29,200
Market Cap$21.79 billion
Next Earnings Date10/24/2019 (Estimated)
OptionableOptionable

Receive CERN News and Ratings via Email

Sign-up to receive the latest news and ratings for CERN and its competitors with MarketBeat's FREE daily newsletter.


Cerner (NASDAQ:CERN) Frequently Asked Questions

What is Cerner's stock symbol?

Cerner trades on the NASDAQ under the ticker symbol "CERN."

How often does Cerner pay dividends? What is the dividend yield for Cerner?

Cerner announced a quarterly dividend on Wednesday, September 11th. Shareholders of record on Wednesday, September 25th will be given a dividend of $0.18 per share on Wednesday, October 9th. This represents a $0.72 dividend on an annualized basis and a yield of 1.05%. The ex-dividend date is Tuesday, September 24th. View Cerner's Dividend History.

How were Cerner's earnings last quarter?

Cerner Co. (NASDAQ:CERN) announced its earnings results on Wednesday, July, 24th. The company reported $0.60 earnings per share for the quarter, beating the Zacks' consensus estimate of $0.58 by $0.02. The business earned $1.43 billion during the quarter, compared to the consensus estimate of $1.44 billion. Cerner had a net margin of 10.75% and a return on equity of 15.14%. The company's revenue was up 4.6% compared to the same quarter last year. During the same period last year, the business posted $0.62 EPS. View Cerner's Earnings History.

When is Cerner's next earnings date?

Cerner is scheduled to release their next quarterly earnings announcement on Thursday, October 24th 2019. View Earnings Estimates for Cerner.

What guidance has Cerner issued on next quarter's earnings?

Cerner issued an update on its FY19 earnings guidance on Wednesday, July, 24th. The company provided EPS guidance of $2.64-2.72 for the period, compared to the Thomson Reuters consensus EPS estimate of $2.67. The company issued revenue guidance of $5.65-5.85 billion, compared to the consensus revenue estimate of $5.74 billion.

What price target have analysts set for CERN?

15 analysts have issued twelve-month price objectives for Cerner's shares. Their predictions range from $54.00 to $85.00. On average, they anticipate Cerner's share price to reach $74.5714 in the next year. This suggests a possible upside of 9.0% from the stock's current price. View Analyst Price Targets for Cerner.

What is the consensus analysts' recommendation for Cerner?

15 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Cerner in the last year. There are currently 1 sell rating, 3 hold ratings and 11 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Cerner.

What are Wall Street analysts saying about Cerner stock?

Here are some recent quotes from research analysts about Cerner stock:
  • 1. According to Zacks Investment Research, "Cerner exited the second quarter on a mixed note. The company continues to witness significant contributions from key areas like Population Health, Revenue Cycle and IT Works. Further, gains in the Licensed software, Professional and Managed Services units buoy optimism. International revenues also improved in recent times. Cerner is likely to benefit from electronic health record (EHR), electronic patient record (EPR) or electronic medical record (EMR) platforms that provide patient care in acute inpatient and outpatient settings. The stock outperformed the industry in a year. Meanwhile, Technology Resale, Support & Maintenance and Reimbursement Travel revenues declined year over year recently. Bookings also fell. Contraction in operating margins remains a concern. Furthermore, competition in the global MedTech space is a woe." (7/29/2019)
  • 2. Cantor Fitzgerald analysts commented, "Our rating remains Overweight and our PT remains $75. Although some amount of investor skepticism regarding the company’s growth outlook continues to temper valuation levels, we do not share those concerns. Our long-term DCF model assumptions are mostly conservative, with high single-digit revenue growth and modest margin expansion. Capital spending should moderate in 2019. We think the shares offer a compelling risk/reward trade off. Valuation Summary Cerner shares trade at a 32% discount to our DCF-based price target of $75." (4/9/2019)

Has Cerner been receiving favorable news coverage?

News articles about CERN stock have been trending somewhat negative on Sunday, InfoTrie Sentiment reports. The research firm ranks the sentiment of press coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of negative five to five, with scores nearest to five being the most favorable. Cerner earned a daily sentiment score of -1.3 on InfoTrie's scale. They also assigned news coverage about the company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an impact on the stock's share price in the next several days. View News Stories for Cerner.

Are investors shorting Cerner?

Cerner saw a increase in short interest in August. As of August 31st, there was short interest totalling 11,027,700 shares, an increase of 5.4% from the July 31st total of 10,467,100 shares. Based on an average trading volume of 2,330,000 shares, the short-interest ratio is currently 4.7 days. Currently, 3.6% of the shares of the stock are short sold. View Cerner's Current Options Chain.

Who are some of Cerner's key competitors?

What other stocks do shareholders of Cerner own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Cerner investors own include Dominion Energy (d), Cisco Systems (CSCO), Gilead Sciences (GILD), NVIDIA (NVDA), QUALCOMM (QCOM), Netflix (NFLX), Celgene (CELG), Micron Technology (MU), Johnson & Johnson (JNJ) and Walt Disney (DIS).

Who are Cerner's key executives?

Cerner's management team includes the folowing people:
  • Mr. David Brent Shafer, Chairman & CEO (Age 62)
  • Mr. Marc G. Naughton, Exec. VP & CFO (Age 64)
  • Mr. Michael R. Nill, Exec. VP & COO (Age 54)
  • Mr. Jeffrey A. Townsend, Exec. VP & Chief of Innovation (Age 55)
  • Mr. John T. Peterzalek, Exec. VP & Chief Client Officer (Age 58)

Who are Cerner's major shareholders?

Cerner's stock is owned by many different of institutional and retail investors. Top institutional shareholders include Vanguard Group Inc. (10.61%), BlackRock Inc. (7.41%), BlackRock Inc. (7.41%), Bank of New York Mellon Corp (4.42%), Parnassus Investments CA (3.20%) and Waddell & Reed Financial Inc. (1.91%). Company insiders that own Cerner stock include Clifford W Illig, David Brent Shafer, Denis A Cortese, Donald Trigg, Jeffrey A Townsend, John J Greisch, John Peterzalek, Julie L Gerberding, Julie M Wilson, Linda M Dillman, Marc G Naughton, Michael Nill, Michael R Battaglioli, R Halsey Wise, Randy D Sims, William D Zollars and Zane M Burke. View Institutional Ownership Trends for Cerner.

Which institutional investors are selling Cerner stock?

CERN stock was sold by a variety of institutional investors in the last quarter, including Mackenzie Financial Corp, Parnassus Investments CA, Fiduciary Management Inc. WI, Nuance Investments LLC, Amundi Pioneer Asset Management Inc., First Trust Advisors LP, Scharf Investments LLC and Los Angeles Capital Management & Equity Research Inc.. Company insiders that have sold Cerner company stock in the last year include Clifford W Illig, Donald Trigg, Jeffrey A Townsend, John Peterzalek, Julie L Gerberding, Julie M Wilson, Linda M Dillman, Marc G Naughton, Michael Nill, Michael R Battaglioli, Randy D Sims and William D Zollars. View Insider Buying and Selling for Cerner.

Which institutional investors are buying Cerner stock?

CERN stock was acquired by a variety of institutional investors in the last quarter, including Nuveen Asset Management LLC, AQR Capital Management LLC, Invesco Ltd., Man Group plc, Vanguard Group Inc., Wedge Capital Management L L P NC, APG Asset Management N.V. and Canada Pension Plan Investment Board. Company insiders that have bought Cerner stock in the last two years include John J Greisch and R Halsey Wise. View Insider Buying and Selling for Cerner.

How do I buy shares of Cerner?

Shares of CERN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Cerner's stock price today?

One share of CERN stock can currently be purchased for approximately $68.44.

How big of a company is Cerner?

Cerner has a market capitalization of $21.79 billion and generates $5.37 billion in revenue each year. The company earns $630.05 million in net income (profit) each year or $2.21 on an earnings per share basis. Cerner employs 29,200 workers across the globe.View Additional Information About Cerner.

What is Cerner's official website?

The official website for Cerner is http://www.cerner.com/.

How can I contact Cerner?

Cerner's mailing address is 2800 ROCKCREEK PKWY W0162, NORTH KANSAS CITY MO, 64117. The company can be reached via phone at 816-221-1024 or via email at [email protected]


MarketBeat Community Rating for Cerner (NASDAQ CERN)

Community Ranking:  3.1 out of 5 (star star star)
Outperform Votes:  947 (Vote Outperform)
Underperform Votes:  596 (Vote Underperform)
Total Votes:  1,543
MarketBeat's community ratings are surveys of what our community members think about Cerner and other stocks. Vote "Outperform" if you believe CERN will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CERN will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 9/22/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel